Medline MDLN
NASDAQ MDLN
$32.58 -1.33 (-3.92%)
As of: Aug 20, 2026 · 3:59 PM EDT

Medline (MDLN) EBITDA (2025 - 2026)

Medline (MDLN) posted quarterly EBITDA of $422.0 million for Q1 2026, down 26.09% year-over-year from $571.0 million in Q1 2025, and down 26.09% quarter-over-quarter from $571.0 million in Q1 2025.

Medline (MDLN) EBITDA (2025 - 2026) Analysis & Trends

Medline (MDLN) has reported EBITDA for 2 consecutive years, with $422.0 million the latest figure, recorded in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Intuitive Surgical 132.71 Bn 127.50 Bn 1.96 Bn 971.90 Mn
2 Becton Dickinson 51.57 Bn 50.71 Bn 2.32 Bn 663.00 Mn
3 Alcon 35.52 Bn 34.17 Bn 1.68 Bn 11.00 Mn
4 Resmed 33.28 Bn 31.81 Bn 861.22 Mn 448.71 Mn
5 Medline 27.86 Bn 25.18 Bn 2.22 Bn 395.00 Mn
6 West Pharmaceutical Services 25.15 Bn 24.71 Bn 329.20 Mn 179.10 Mn
7 Solventum 15.31 Bn 14.91 Bn 1.29 Bn 181.00 Mn
8 Cooper Companies 14.86 Bn 14.72 Bn 735.40 Mn -31.00 Mn
9 Baxter International 13.63 Bn 11.48 Bn 1.03 Bn 217.00 Mn
10 Align Technology 11.37 Bn 10.27 Bn 757.43 Mn 154.01 Mn

Historic Data

Download Data
DateValue
Jun 27, 2026 395.00 Mn
Mar 28, 2026 422.00 Mn
Mar 29, 2025 571.00 Mn